LINGO-1 regulates oligodendrocyte differentiation by inhibiting ErbB2 translocation and activation in lipid rafts

Molecular and Cellular Neuroscience

Volumn 60, Issue , 2014, Pages 36-42

  Lee, Xinhua ^a   Shao, Zhaohui ^a   Sheng, Guoqing ^a   Pepinsky, Blake ^a   Mi, Sha ^a  

^a BIOGEN   (United States)

Author keywords

ErbB2; LINGO 1; Lipid raft; Multiple sclerosis; Oligodendrocyte

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; LEUCINE RICH REPEAT AND IMMUNOGLOBULIN DOMAIN CONTAINING NOGO RECEPTOR INTERACTING PROTEIN 1; MEMBRANE PROTEIN; MYELIN BASIC PROTEIN; UNCLASSIFIED DRUG; ERBB2 PROTEIN, HUMAN; LINGO1 PROTEIN, HUMAN; NERVE PROTEIN; PROTEIN BINDING;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LIPID RAFT; MOUSE; NERVE CELL DIFFERENTIATION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; ANIMAL; CELL CULTURE; CELL MEMBRANE; CHO CELL LINE; CRICETULUS; CYTOLOGY; HAMSTER; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; PHOSPHORYLATION;

ANIMALS; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MICE; NERVE TISSUE PROTEINS; NEUROGENESIS; OLIGODENDROGLIA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTOR, ERBB-2;

EID: 84897832359     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2014.02.006     Document Type: Article

References (51)

1. Assanah M.C., Bruce J.N., Suzuki S.O., Chen A., Goldman J.E., Canoll P. PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain. Glia 2009, 57:1835-1847. 10.1002/glia.20895.
2. Brinkmann B.G., Agarwal A., Sereda M.W., Garratt A.N., Müller T., Wende H., Stassart R.M., Nawaz S., Humml C., Velanac V., et al. Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 2008, 59(4):581-595. 10.1016/j.neuron.2008.06.028.
3. Chan J.R., Watkins T.A., Cosgaya J.M., Zhang C., Chen L., Reichardt L.F., Shooter E.M., Barres B.A. NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 2004, 43:183-191. 10.1016/j.neuron.2004.06.024.
4. Charles P., Hernandez M.P., Stankoff B., Aigrot M.S., Colin C., Rougon G., Zalc B., Lubetzki C. Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:7585-7590. 10.1073/pnas.100076197.
5. Csordas G., Santra M., Reed C.C., Eichstetter I., McQuillan D.J., Gross D., Nugent M.A., Hajnoczky G., Iozzo R.V. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J. Biol. Chem. 2000, 275:32879-32887. 10.1074/jbc.M005609200.
6. Fancy S.P., Baranzini S.E., Zhao C., Yuk D.I., Irvine K.A., Kaing S., Sanai N., Franklin R.J., Rowitch D.H. Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev. 2009, 23:1571-1585. 10.1101/gad.1806309.
7. Fox I.J., Kornblum H.I. Developmental profile of ErbB receptors in murine central nervous system: implications for functional interactions. J. Neurosci. Res. 2005, 79:584-597. 10.1002/jnr.20381.
8. Fu J., Jiang M., Mirando A.J., Yu H.M., Hsu W. Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18598-18603. 10.1073/pnas.0904894106.
9. Gee J.M., Robertson J.F., Gutteridge E., Ellis I.O., Pinder S.E., Rubini M., Nicholson R.I. Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocr. Relat. Cancer. 2005, 12(Suppl. 1):S99-S111. 10.1677/erc.1.01005.
10. Ghiglione C., Carraway K.L., Amundadottir L.T., Boswell R.E., Perrimon N., Duffy J.B. The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis. Cell 1999, 96:847-856.
11. Gur G., Rubin C., Katz M., Amit I., Citri A., Nilsson J., Amariglio N., Henriksson R., Rechavi G., Hedman H., et al. LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation. EMBO J. 2004, 23:3270-3281. 10.1038/sj.emboj.7600342.
12. Ha H., Kwak H.B., Lee S.K., Na D.S., Rudd C.E., Lee Z.H., Kim H.H. Membrane rafts play a crucial role in receptor activator of nuclear factor kappaB signaling and osteoclast function. J. Biol. Chem. 2003, 278:18573-18580. 10.1074/jbc.M212626200.
13. Holbro T., Hynes N.E. ErbB receptors: directing key signaling networks throughout life. Annu. Rev. Pharmacol. Toxicol. 2004, 44:195-217. 10.1146/annurev.pharmtox.44.101802.121440.
14. Hu Q.D., Ang B.T., Karsak M., Hu W.P., Cui X.Y., Duka T., Takeda Y., Chia W., Sankar N., Ng Y.K., et al. F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 2003, 115:163-175.
15. Inoue H., Lin L., Lee X., et al. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(36):14430-14435. 10.1073/pnas.0700901104.
16. Ji B., Li M., Wu W.T., Yick L.W., Lee X., Shao Z., Wang J., So K.F., McCoy J.M., Pepinsky R.B., et al. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol. Cell. Neurosci. 2006, 33:311-320. 10.1016/j.mcn.2006.08.003.
17. Kim J.Y., Sun Q., Oglesbee M., Yoon S.O. The role of ErbB2 signaling in the onset of terminal differentiation of oligodendrocytes in vivo. J. Neurosci. 2003, 23:5561-5571.
18. Klapper L.N., Vaisman N., Hurwitz E., Pinkas-Kramarski R., Yarden Y., Sela M. A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors. Oncogene 1997, 14:2099-2109. 10.1038/sj.onc.1201029.
19. Kolodny E.H. Dysmyelinating and demyelinating conditions in infancy. Curr. Opin. Neurol. Neurosurg. 1993, 6:379-386.
20. Laederich M.B., Funes-Duran M., Yen L., Ingalla E., Wu X., Carraway K.L., Sweeney C. The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases. J. Biol. Chem. 2004, 279:47050-47056. 10.1074/jbc.M409703200.
21. Lee X., Yang Z., Shao Z., Rosenberg S.S., Levesque M., Pepinsky R.B., Qiu M., Miller R.H., Chan J.R., Mi S. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J. Neurosci. 2007, 27:220-225. 10.1523/JNEUROSCI.4175-06.2007.
22. Makinodan M., Rosen K.M., Ito S., Corfas G. A critical period for social experience-dependent oligodendrocyte maturation and myelination. Science 2012, 337:1357-1360. 10.1126/science.1220845.
23. Mela A., Goldman J.E. CD82 blocks cMet activation and overcomes hepatocyte growth factor effects on oligodendrocyte precursor differentiation. J. Neurosci. 2013, 33:7952-7960. 10.1523/JNEUROSCI.5836-12.2013.
24. Mi S., Lee X., Shao Z., Thill G., Ji B., Relton J., Levesque M., Allaire N., Perrin S., Sands B., et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci. 2004, 7:221-228. 10.1038/nn1188.
25. Mi S., Miller R.H., Lee X., Scott M.L., Shulag-Morskaya S., Shao Z., Chang J., Thill G., Levesque M., Zhang M., et al. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 2005, 8:745-751. 10.1038/nn1460.
26. Mi S., Hu B., Hahm K., Luo Y., Kam Hui E.S., Yuan Q., Wong W.M., Wang L., Su H., Chu T.H., et al. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat. Med. 2007, 13:1228-1233. 10.1038/nm1664.
27. Mi S., Miller R.H., Tang W., Lee X., Hu B., Wu W., Zhang Y., Shields C.B., Zhang Y., Miklasz S., et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann. Neurol. 2009, 65:304-315. 10.1002/ana.21581.
28. Mocanu M.M., Fazekas Z., Petras M., Nagy P., Sebestyen Z., Isola J., Timar J., Park J.W., Vereb G., Szollosi J. Associations of ErbB2, beta1-integrin and lipid rafts on Herceptin (Trastuzumab) resistant and sensitive tumor cell lines. Cancer Lett. 2005, 227:201-212. 10.1016/j.canlet.2005.01.028.
29. Nagy P., Vereb G., Sebestyen Z., Horvath G., Lockett S.J., Damjanovich S., Park J.W., Jovin T.M., Szollosi J. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2. J. Cell Sci. 2002, 115:4251-4262.
30. Ohya W., Funakoshi H., Kurosawa T., Nakamura T. Hepatocyte growth factor (HGF) promotes oligodendrocyte progenitor cell proliferation and inhibits its differentiation during postnatal development in the rat. Brain Res. 2007, 1147:51-65. 10.1016/j.brainres.2007.02.045.
31. Park S.K., Miller R., Krane I., Vartanian T. The erbB2 gene is required for the development of terminally differentiated spinal cord oligodendrocytes. J. Cell Biol. 2001, 154:1245-1258. 10.1083/jcb.200104025.
32. Pike L.J. Lipid rafts: bringing order to chaos. J. Lipid Res. 2003, 44:655-667. 10.1194/jlr.R200021-JLR200.
33. Pike L.J. Growth factor receptors, lipid rafts and caveolae: an evolving story. Biochim. Biophys. Acta 2005, 1746:260-273. 10.1016/j.bbamcr.2005.05.005.
34. Qiu X.B., Goldberg A.L. Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:14843-14848. 10.1073/pnas.232580999.
35. Rubin I., Yarden Y. The basic biology of HER2. Ann. Oncol. 2001, 12(Suppl. 1):S3-S8.
36. Schmucker J., Ader M., Brockschnieder D., Brodarac A., Bartsch U., Riethmacher D. erbB3 is dispensable for oligodendrocyte development in vitro and in vivo. Glia 2003, 44:67-75. 10.1002/glia.10275.
37. S Mostaert A., Crockett R., Kearn G., Cherny I., Gazit E., C Serpell L., P Jarvis S. Mechanically functional amyloid fibrils in the adhesive of a marine invertebrate as revealed by Raman spectroscopy and atomic force microscopy. Arch. Histol. Cytol. 2009, 72:199-207.
38. Shao Z., Browning J.L., Lee X., Scott M.L., Shulga-Morskaya S., Allaire N., Thill G., Levesque M., Sah D., McCoy J.M., et al. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 2005, 45:353-359. 10.1016/j.neuron.2004.12.050.
39. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1:31-39. 10.1038/35036052.
40. Sussman C.R., Vartanian T., Miller R.H. The ErbB4 neuregulin receptor mediates suppression of oligodendrocyte maturation. J. Neurosci. 2005, 25:5757-5762. 10.1523/JNEUROSCI.4748-04.2005.
41. Trapp B.D., Bo L., Mork S., Chang A. Pathogenesis of tissue injury in MS lesions. J. Neuroimmunol. 1999, 98:49-56.
42. Trapp B.D., Ransohoff R., Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol. 1999, 12:295-302.
43. Tzahar E., Pinkas-Kramarski R., Moyer J.D., Klapper L.N., Alroy I., Levkowitz G., Shelly M., Henis S., Eisenstein M., Ratzkin B.J., et al. Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J. 1997, 16:4938-4950. 10.1093/emboj/16.16.4938.
44. van Heyningen P., Calver A.R., Richardson W.D. Control of progenitor cell number by mitogen supply and demand. Curr. Biol. 2001, 11:232-241.
45. Vartanian T., Goodearl A., Viehover A., Fischbach G. Axonal neuregulin signals cells of the oligodendrocyte lineage through activation of HER4 and Schwann cells through HER2 and HER3. J. Cell Biol. 1997, 137:211-220.
46. Vartanian T., Fischbach G., Miller R. Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:731-735.
47. Wang S., Sdrulla A.D., diSibio G., Bush G., Nofziger D., Hicks C., Weinmaster G., Barres B.A. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 1998, 21:63-75.
48. Xu W., Marcu M., Yuan X., Mimnaugh E., Patterson C., Neckers L. Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:12847-12852. 10.1073/pnas.202365899.
49. Yan H., Rivkees S.A. Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J. Neurosci. Res. 2002, 69:597-606. 10.1002/jnr.10323.
50. Yarden Y., Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2001, 2:127-137. 10.1038/35052073.
51. Zhou P., Fernandes N., Dodge I.L., Reddi A.L., Rao N., Safran H., DiPetrillo T.A., Wazer D.E., Band V., Band H. ErbB2 degradation mediated by the co-chaperone protein CHIP. J. Biol. Chem. 2003, 278:13829-13837. 10.1074/jbc.M209640200.